Today’s guest is Dr Rohit Katial, a Research Physician involved in Early Phase Clinical Trials in New Zealand.

This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/

Unfortunately, in New Zealand our access to modern medicines is well behind our OECD peers, and it typically takes 10 years before a new medicine is funded by Pharmac after being approved by Medsafe. Thus, Clinical Research is starting to do more and more of the heavy lifting to fill the gap between need and access.

An interesting component of ClinicalResearch is Early Phase trials - which range from firstinhuman trials, to the initial studies in patients i.e., single ascending dose or multiple-ascending dose studies, aptly shortened to SAD or MAD trials.

New Zealand is increasingly becoming an attractive place to conduct Early Phase research, by virtue of our diverse & young population, less onerous regulatory requirements and skilled workforce. 

Despite this, early phase ClinicalResearch is not an obvious career choice for those studying or participating in medicine. This is a challenge that will need to be addressed if we are to make the most of the opportunity that is before us.

In this episode, Dr Rohit Katial and I discuss:
1. His journey from mainstream medicine to early phase clinical research
2. the core skillset that is needed to be proficient as an early phase clinical trials investigator
3. Some of the exciting trials Rohit has been a part of....hint: gene editing

You can find out more about Rohit and New Zealand Clinical Research here: https://www.linkedin.com/in/rohit-katial/ https://www.linkedin.com/company/nzcr-christchurch/ https://www.nzcr.co.nz/

#newzealand #clinicalresearch #innovation #podcast #clinicalresearchassociate #principalinvestigator #clinicaltrials #CRISPr #geneediting